https://orcid.org/0000-0001-7922-9024
References
- DalmauJ, GrausF. Antibody-mediated encephalitis. N. Engl. J. Med.378, 840–851 (2018).
- López-ChiribogaAS, ClardySL. Emerging subspecialties in neurology: autoimmune neurology. Neurology89, e129–e133 (2017).
- DalmauJ. NMDA receptor encephalitis and other antibody-mediated disorders of the synapse. Neurology87, 2471–2482 (2016).
- ZulianiL, NosadiniM, GastaldiMet al.Management of antibody-mediated autoimmune encephalitis in adults and children: literature review and consensus-based practical recommendations. Neurol Sci.40, 2017–2030 (2019).
- DubeyAD, PittockSJ, KellyCRet al.Autoimmune Encephalitis Epidemiology and a comparison to infectious encephalitis. Ann. Neurol.83, 166–177 (2018).
- GrausF, TitulaerMJ, BaluRet al.A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol.15, 391–404 (2016).
- ZulianiL, ZoccaratoM, GastaldiMet al.Diagnostics of autoimmune encephalitis associated with antibodies against neuronal surface antigens. Neurol Sci.38, 225–229 (2017).
- ZoccaratoM, GastaldiM, ZulianiLet al.Diagnostics of paraneoplastic neurological syndromes. Neurol. Sci.38, 237–242 (2017).
- GeschwindMD, ShuH, HamanAet al.Rapidly progressive dementia. Ann. Neurol.64, 97–108 (2008).
- SabaterL, GaigC, GelpiEet al.A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study. Lancet Neurol.13, 575–586 (2014).
- TüzünE, RossiJE, KarnerSFet al.Adenylate kinase 5 autoimmunity in treatment refractory limbic encephalitis. J. Neuroimmunol.186, 177–180 (2007).
- BienCI, NehlsF, KollmarRet al.Identification of adenylate kinase 5 antibodies during routine diagnostics in a tissue-based assay: three new cases and a review of the literature. J. Neuroimmunol.334, 1–6 (2019).
- ZoccaratoM, ValeggiaS, ZulianiLet al.Conventional brain MRI features distinguishing limbic encephalitis from mesial temporal glioma. Neuroradiology61(8), 853–860 (2019).
- ArmangueT, SpatolaM, VlageaAet al.Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis. Lancet Neurol.17, 760–772 (2018).
- CohenDA, SebastianLopez-Chiriboga A, PittockSJet al.Posttransplant autoimmune encephalitis. Neurol. Neuroimmunol. NeuroInflamm.5, 4–6 (2018).
- GiarolaB, MasseyJ, BarnettYet al.Autoimmune encephalitis following alemtuzumab treatment of multiple sclerosis. Mult. Scler. Relat. Disord.28, 31–33 (2019).
- YshiiLM, HohlfeldR, LiblauRS. Inflammatory CNS disease caused by immune checkpoint inhibitors: status and perspectives. Nat. Rev. Neurol.13, 755–763 (2017).
- GrausF, DalmauJ. Paraneoplastic neurological syndromes in the era of immune-checkpoint inhibitors. Nat. Rev. Clin. Oncol. Mar.16(9), 535–548 (2019).
- PollakTA, LennoxBR, MüllerSet al.Autoimmune psychosis: an international consensus on an approach to the diagnosis and management of psychosis of suspected autoimmune origin. Lancet Neurol.S2215-0366(19), 30290–30291 (2019).
- DubeyD, BrittonJ, MckeonAet al.Randomized placebo controlled trial of IVIG in autoimmune LGI1/CASPR2 epilepsy. Ann. Neurol.87(2), 313–323 (2019).
- GrausF, EscuderoD, OleagaLet al.Syndrome and outcome of antibody-negative limbic encephalitis. Eur. J. Neurol.25, 1011–1016 (2018).
- GastaldiM, MariottoS, GiannoccaroMPet al.Subgroup comparison according to clinical phenotype and serostatus in autoimmune encephalitis: a multicenter retrospective study. Eur. J. Neurol.27(4), 633–643 (2020).